Noriyuki Tsumaki Selected Research

pterosin B

3/2016	Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3.
1/2016	Corrigendum: Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3.
7/2015	Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriyuki Tsumaki Research Topics

Disease

4	Osteoarthritis 01/2021 - 11/2004
4	Hypertrophy 03/2016 - 12/2011
2	Teratoma (Teratoid Tumor) 01/2022 - 01/2015
2	Achondroplasia 12/2020 - 09/2014
2	Neoplasms (Cancer) 12/2020 - 11/2002
2	Intervertebral Disc Degeneration 12/2017 - 04/2014
2	Congenital Abnormalities (Deformity) 11/2009 - 11/2004
1	Pain (Aches) 12/2017
1	Cartilage Diseases (Cartilage Disease) 08/2015
1	Hepatocellular Carcinoma (Hepatoma) 07/2015
1	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 09/2014
1	Scoliosis 01/2012
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2012
1	Syndactyly (Polysyndactyly) 11/2009
1	Rheumatoid Arthritis 01/2008
1	Osteoporosis 01/2008
1	Hypoxia (Hypoxemia) 10/2006
1	Sarcoma (Soft Tissue Sarcoma) 03/2003
1	Chondrosarcoma 11/2002
1	type 2 alpha 1 Collagenopathy 06/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 12/2020 - 08/2015
3	pterosin BIBA 03/2016 - 07/2015
3	Proteins (Proteins, Gene)FDA Link 04/2014 - 03/2003
2	Phosphotransferases (Kinase)IBA 03/2016 - 03/2012
2	SaltsIBA 03/2016 - 03/2012
1	Histocompatibility Antigens Class IIBA 01/2022
1	SolutionsIBA 01/2021
1	ASP5878IBA 12/2020
1	Mutant Proteins (Protein, Mutant)IBA 12/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2017
1	3- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA 12/2017
1	Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA 07/2015
1	Glucose (Dextrose)FDA LinkGeneric 07/2015
1	GlycogenIBA 07/2015
1	Collagen Type II (Type II Collagen)IBA 01/2015
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 09/2014
1	Natriuretic PeptidesIBA 01/2012
1	Alitretinoin FDA Link 01/2012
1	atrial natriuretic factor receptor CIBA 01/2012
1	Parathyroid Hormone-Related ProteinIBA 12/2011
1	GlucocorticoidsIBA 01/2008
1	GlycosaminoglycansIBA 10/2006
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2006
1	Bone Morphogenetic Protein 2IBA 10/2006
1	Collagen Type XIBA 10/2006
1	Alkaline PhosphataseIBA 10/2006
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2006
1	Oxygen (Dioxygen)IBA 10/2006
1	LuciferasesIBA 03/2003
1	CollagenIBA 03/2003
1	Aggrecans (Aggrecan)IBA 11/2002
1	Messenger RNA (mRNA)IBA 11/2002
1	RNA IsoformsIBA 11/2002
1	Protein Isoforms (Isoforms)IBA 11/2002
1	Collagen Type XIIBA 06/2002

Therapy/Procedure

2	Therapeutics 08/2015 - 01/2008
1	Transplantation 01/2022
1	Punctures 12/2017
1	Oral Administration 12/2017
1	Intra-Articular Injections 03/2016
1	Osteotomy 11/2004